Stay updated with breaking news from Nasdaq kpti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) have been given an average recommendation of “Moderate Buy” by the five ratings firms that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month […] ....
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.15 and traded as low as $0.69. Karyopharm Therapeutics shares last traded at $0.77, with a volume of 1,320,715 shares changing hands. Wall Street Analysts Forecast Growth KPTI […] ....
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) has been given an average rating of “Moderate Buy” by the six brokerages that are currently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price among […] ....
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month price […] ....
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) has been assigned an average rating of “Moderate Buy” from the six ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price […] ....